# Hypofractionated Radiation Therapy for Merkel Cell Carcinoma

> **NCT05100095** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 52 (estimated)

## Conditions studied

- Merkel Cell Carcinoma

## Interventions

- **DRUG:** Radiation therapy

## Key facts

- **NCT ID:** NCT05100095
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-14
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05100095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05100095, "Hypofractionated Radiation Therapy for Merkel Cell Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05100095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*